These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28120767)
1. [A new toolbox for genome editing]. Jordan B Med Sci (Paris); 2017 Jan; 33(1):105-108. PubMed ID: 28120767 [TBL] [Abstract][Full Text] [Related]
2. [A new milestone in human embryo editing]. Jordan B Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733 [TBL] [Abstract][Full Text] [Related]
3. CRISPR-Mediated Base Editing without DNA Double-Strand Breaks. Plosky BS Mol Cell; 2016 May; 62(4):477-8. PubMed ID: 27203175 [TBL] [Abstract][Full Text] [Related]
4. Gene editing flows to the lungs. Bulcaen M; Carlon MS Science; 2024 Jun; 384(6701):1175-1176. PubMed ID: 38870313 [TBL] [Abstract][Full Text] [Related]
6. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found. Carlson B Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891 [No Abstract] [Full Text] [Related]
7. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing. Maule G; Arosio D; Cereseto A Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152 [TBL] [Abstract][Full Text] [Related]
11. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future. Luo J Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053 [No Abstract] [Full Text] [Related]
12. Treating Cystic Fibrosis with mRNA and CRISPR. Da Silva Sanchez A; Paunovska K; Cristian A; Dahlman JE Hum Gene Ther; 2020 Sep; 31(17-18):940-955. PubMed ID: 32799680 [TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Kim EJ; Kang KH; Ju JH Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282 [TBL] [Abstract][Full Text] [Related]
15. New Gene-Editing Tool Slowly Advances Into the Clinic. Jenks S J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363 [No Abstract] [Full Text] [Related]
16. Site-Specific Genome Engineering in Human Pluripotent Stem Cells. Merkert S; Martin U Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935 [TBL] [Abstract][Full Text] [Related]
17. Genome editing: A breakthrough in life science and medicine. Hatada I; Horii T Endocr J; 2016; 63(2):105-10. PubMed ID: 26698412 [TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery. Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612 [TBL] [Abstract][Full Text] [Related]
20. Marker-free coselection for CRISPR-driven genome editing in human cells. Agudelo D; Duringer A; Bozoyan L; Huard CC; Carter S; Loehr J; Synodinou D; Drouin M; Salsman J; Dellaire G; Laganière J; Doyon Y Nat Methods; 2017 Jun; 14(6):615-620. PubMed ID: 28417998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]